Asimilar Group Plc

Delisting Announcement • Feb 14, 2020

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 1166D

Asimilar Group PLC

14 February 2020

Asimilar Group plc

("Asimilar" or the "Company")

Statement re Suspension

Asimilar Group Plc, the AIM quoted investment company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT) notes a press article that states that the Company is to acquire a stake in a Belgium AI company named Sentiance NV ("Sentiance").

The Board confirms that the Company has signed a non-binding term sheet concerning an investment in Sentiance, which, subject to contract, may or may not be considered to be a reverse takeover transaction.  Whilst work continues on this investment, the Company's shares have been suspended pursuant to AIM Rule 40.

The Company's shares will remain suspended until such time as the Company publishes an admission document or discussions in relation to a possible reverse takeover transaction cease.

The Company is continuing to work with Sentiance to finalise binding legal documentation, although there is no guarantee that a formal agreement will be reached.

Further announcements will be made in due course.

This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.

**ENDS**

Enquiries

Asimilar Group plc
John Taylor, Non-Executive Chairman	via Buchanan
Cairn Financial Advisers LLP
Sandy Jamieson, Liam Murray	Tel: +44 20 7213 0880
Peterhouse Capital Limited
Duncan Vasey / Lucy Williams	Tel: + 44 20 7220 9797
Buchanan Communications Limited
Richard Oldworth / Chris Lane	Tel: +44 (0) 20 7466 5000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

STRKKQBQABKDDBD